Company Ticker News February 2, 2022Cramer's Investing Club: We're encouraged AbbVie shares held recent gains after a mixed quarter 0 0 Share
Company Ticker News February 2, 2022AbbVie Expects Solid FY22 As Botox, Skyrizi Power Q4 Earnings 0 0 Share
Company Ticker News February 2, 2022AbbVie's stock gains on fourth-quarter earnings as it reports better-than-expected sales of Humana 0 0 Share
Company Ticker News February 2, 2022AbbVie forecasts 2022 profit above estimates on strong sales of Botox, Skyrizi 0 0 Share
Press Release February 1, 2022AbbVie Showcases Its Leadership in Research in Inflammatory Bowel Diseases with New Analyses to be Presented at the 17th Congress of European Crohn's and Colitis Organization (ECCO) 0 0 Share
Company Ticker News February 1, 20223 Pharmaceutical Stocks With Dividend Yields of 2.9% or Better 0 0 Share
Company Ticker News February 1, 2022AbbVie Can Continue Generating Substantial Shareholder Returns 0 0 Share
Company Ticker News January 31, 2022'Blue Chip' You Cannot Afford To Miss, Yield 4.1%: AbbVie 0 0 Share
